Fungi and Protozoa, Malaria
Deactivation of Toxins – Botulism et al – Snake bite, Poison Ivy,
Lyme’s Disease, Pancreatic cancer and Non Healing wounds
http://compbio.mit.edu/wiki/images/?pdf=general-paper-essays-on-education how to start a business plan https://library.citytech.cuny.edu/podcast/article.php?publish=4-person-dialogue-essay-format the purple pharmacy algodones letter writing paper for first grade best mba essay ghostwriters services au purchase essays go abilify 400 mg cuanto tiempo hace efecto cialis http://hyperbaricnurses.org/3236-mark-martin-viagra-photo/ viagra 25mg online enter arelix ace wirkstoff cialis order finance homework cialis 20 mg nedir lester b pearson greatest canadian essay https://cadasb.org/pharmacy/no-prescription-prednisone-online/13/ service recovery thesis get headache after sex levitra go to link another word for example in essay citing literary response essay examples https://efm.sewanee.edu/faq/event-management-thesis-pdf/22/ lamborghini labs nolvadex achievement desire essays gcse maths coursework t totals writer service go site get link argument essay poster frutas como viagra Bronchial Asthma
One study showed positive results of an 80 patient case study
With Bronchial Asthma comparing hundreds of patients. LBI and UBI’s were very similar. Both conveyed a “beautiful therapeutic effect.”
(Sukhanova, “Laser Therapy in…”)
Fungi and Protozoa
UBI has been effectively used for malaria.
A Russian study on Candidiasis resulted in the cure of 8 out of 10 cases
(Frick, “Fibel der Ultrviolettbestrahlung…”)
Deactivation of Toxins – Botulism et al – snake bite, poison Ivy
A single treatment on a woman in a coma with advanced botulism brought her back to health in 13 days.
On non-healing wounds, six cases were observed. All the patients responded very well to UBI.
Also check out the Harrismed.com web site for non healing wounds. UBI has proven to be effective in this area.
Biliary Disease encompasses a wide spectrum of disorders caused by abnormalities in bile composition. Dr. Olney treated 383 patients with this disease in the mid 1940’s. Three were almost moribund, and five very severe, 264 chronic without stones, 56 chronic with stones, 55 had chronic cholangitis and hepatitis, with the gall bladder previously removed.
The three almost moribund all recovered 2 left the hospital in 24 and 18 days and were in good health one year later. 4 of the 5 of the severe recovered without an operation. The others in the groups had good recoveries some with operations. He reported that UBI had great effects in limiting peritonitis, ileus, pain, pulmonary complications and phlebitis.
In 1950 Dr. Rebbeck reported similar successes. Comparing 110 patients who had UBI with 226 patients who did not.
Excessive nausea, vomiting and use of untubation in the UBI – 2.7% control – 33.1%
Excessive abdominal distension – UBI – 11.8% control – 28.8%
Temperatures above 102 – UBI – 15.4% control – 32.3%
Mortality – UBI – .09% Control – 2.2%
Cholecystitis (inflammation from Gallstones)
Postoperative in elderly patients was studied.
- Control Group of 16 received standard srugs
- Group 2 of 20 received extracorporeal x-ray radiation of blood
- Group 3 of 20 received UBI
- Group 4 of 19 got donor blood that had a type of UBI
Study showed that all of three of the groups had better results than the control. Again this study had diminishing effects because of its lack of objective basis of comparison.
Another study had 45 healthy controls and 130 patients with acute cholecustitis. One group of 85 received LBI and another received 40 standard medications. Researchers found that LBI significantly superior to standard therapy.
(Sukhanova, “Laser Therapy in the…”)
Fourteen cases of necrotizing pancreatitis. Ten were diagnosed with hemorrhagic pancreonecrosis while 8 were in serious condition with symptoms of enzymatic toxemia. No controls were used during this study. After a barrage of other therapies failed to produce results they were given 1ml per KG of body weight of UBI donor plasma. Levels of enzymatic toxemia dropped by more than 2 times to near normal levels only 5 to 6 hours after the infusion. Insulin resistance declined and other indicators improve.
In another study 65 patients with acute pancreatitis were treated with an average of 1.5 UBI treatments pre and post operative. Some were treated with UBI and had no surgery. Researchers found that in UBI patients – appetites improved, tachycardia lessened, fever declines and lab results normalized. Evidence of immunostimulation was present with no side effects from the UBI. The study is flawed because its lack of controls and the low number of UBI treatments.
In a third study, with 60 patients 47 had chronic pancreatitis and 13 acute pancreatitis, patients received 5-7 LBI treatments following failure of standard drugs. 92% saw pain reduction and vomiting, 83% lessened nausea, 87% improved appetite, 83% reduction of belly distention. As an indicator of improved functioning pancreas, in the acute cases the level of amylase in the urine dropped from 1826.82 +/- 401.4 to 52.77 +/- 4.9 g/l (p<.05)
In early American studies, UBI suppressed inflammation, relaxed the sphincter of Oddi, and returned amylase and lipase values to normal.
(Miley, “Ultraviolet Blood Irradiation…”)
Some early American studies in 1942 with 72 patients (no controls) with 29 who had tried and failed sulfa therapy were divided in to three groups. All were treated with UBI, 40 with general peritonitis, 20 with abdominal abscesses and 12 females with multiple pelvic abscesses and severe pelvic peritonitis. 43 had moderately advanced peritonitis – all fo these recovered after UBI treatments. 29 were apparently moribund of these 9 out of 17 recovered in group recovered, 4 out of 7 of the second group and 6 out of 9 of the third group. The other moribund patients died, two of sigmoid carcinoma. The researchers noted that UBI treatments rapidly resolved papalytic ileus and led to rapid detoxification.
More recent study 35 patients with disseminated peritonitis found that with UBI treatment it reduced the mortality to 4 out of 35 vs. 10 out of 37 in the control group who were treated with standard combination therapy but without UBI. The UBI group also saw a sharp increase in the number of T-cells (60%) as well asa decrease in circulating immunocomplexes (36.5%). Patients received about 3 treatments each.
A study on kidney disease consisted of 12 patients with chronic glomerulonephritis being treated with LBI. Favorable results incurred; Proteinuria dropped from 1.34 to 0.71. Then 7 patients with hypertonic disease saw a reduction in systolic blood pressure from 180 to 145 and diastolic from 118 to 88.
LBI treatment in 61 chronic pyelonephritis patients, 67.4% with urolithiasis and 32.6% with adenoma of the prostate.
Group 1 – received standard antibiotic therapy – success rate 20.0%
Group 2 – 11 received local laser therapy – success rate 57.1%
Group 3 – 33 received LBI — success rate 64.3%
Researchers concluded that LBI shows “bactericidal action, activated the metabolism of substances and improved microcirculation and rheological properties of the blood. It leads to the removal of all hypoxia, it effects the release of a cascade of the patient’s own central and peripheral autoregulating systems adaptation, which medical substances do not.”
According to Miley, 12 patients with longstanding migraine headaches. Eleven commented they had “striking improvement”, while seven patients needed maintenance treatments every two months.
(Miley, “Ultraviolet Blood Irradiation…”)
East Germany [this is an older study] has used it extensively. Placebo studies, comparative studies, and UBI therapy were all looked at and the conclusion was “UBI is clearly superior…”. According to this study, 21 patients were part of a double blind study. Out of this group, 2 ended up free of complaints, 5 noted significant improvement, 6 some improvements, and 8 had no change. From a number of his studies 60-80% of migraine patients benefited from UBI, some of them even becoming headache free.
87 Patients with burnis covering 3-60% of the body surface – 56 were IIIB-IV degree from 2-38% of the body surface. IN the first few days their mood improved, sleep normalized, appetites rose amd intenseness of pain diminished – drug reduced. Pneumonias disappeared. Epithelization of the surface II and IIIA degree burns took place. Hospitalization shortened from 33.9 days to 26.2 days with those having UBI treatments.
(Ganelina, “Mechanisms of the Influence of Blood…”)
UBI has shown to be highly effective against viral and autoimmune eye disorders. In this study, 73% of the patients with iridocyclitis and uveitis were cured in 4 to 5 weeks. Another 15% were cured after further UBI treatment.
Yeliserva documented 16 patient with relapsing chronic kerartitis and uveitis. All 16 of the patients responded with sharpened visual acuity, resorption of corneal precipitate and other improvements.
A Russian study included 50 men suffering from excretory infertility from ages 21 to 39. Half of the patients received standard therapy with UBI, the other 25 only received the standard procedure. The group receiving UBI treatment noticed improvement in sleep and appetite, had less oligospermia, and higher numbers of motile sperm.
Ten pregnancies occurred in the UBI group while 6 occurred in the control group.